{"title":"将阿巴拉契亚的阿片类药物解决支出与证据和新出现的威胁保持一致。","authors":"Bradley Firchow","doi":"10.13023/jah.0703.01","DOIUrl":null,"url":null,"abstract":"<p><p>State and local governments across Appalachia are allocating opioid-settlement dollars over the coming years. This funding opportunity can support lasting public health infrastructure or be spent on short-term programs anchored in the opioid crisis of the past. Evidence indicates that emerging synthetic drugs such as nitazenes and xylazine are altering overdose risk patterns in ways that require urgent policy attention.</p>","PeriodicalId":73599,"journal":{"name":"Journal of Appalachian health","volume":"7 3","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12440308/pdf/","citationCount":"0","resultStr":"{\"title\":\"Align Appalachia's Opioid-Settlement Spending with Evidence and Emerging Threats.\",\"authors\":\"Bradley Firchow\",\"doi\":\"10.13023/jah.0703.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>State and local governments across Appalachia are allocating opioid-settlement dollars over the coming years. This funding opportunity can support lasting public health infrastructure or be spent on short-term programs anchored in the opioid crisis of the past. Evidence indicates that emerging synthetic drugs such as nitazenes and xylazine are altering overdose risk patterns in ways that require urgent policy attention.</p>\",\"PeriodicalId\":73599,\"journal\":{\"name\":\"Journal of Appalachian health\",\"volume\":\"7 3\",\"pages\":\"1-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12440308/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Appalachian health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.13023/jah.0703.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Appalachian health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13023/jah.0703.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Align Appalachia's Opioid-Settlement Spending with Evidence and Emerging Threats.
State and local governments across Appalachia are allocating opioid-settlement dollars over the coming years. This funding opportunity can support lasting public health infrastructure or be spent on short-term programs anchored in the opioid crisis of the past. Evidence indicates that emerging synthetic drugs such as nitazenes and xylazine are altering overdose risk patterns in ways that require urgent policy attention.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
